drugset / Trial / NCT01138215

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

NCT01138215 ↗

NaSingle-groupOpen-labelPrevention

Summary

To study about the immunogenicity, safety and efficacy of varicella-zoster virus vaccine in HIV-infected children.

Timeline

Start
2009-06
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject VZV vaccination Vaccine 0.5 ml Subcutaneous